Clinical investigations have revealed that lower LINC01089 expression correlates with higher tumor staging and regional lymph node metastasis, highlighting the significant potential of LINC01089 as a prognostic marker for thyroid cancer. Here, LINC01089 is linked to thyroid cancer.